The first thing that struck Shen Yunxiang when he descended into the bowels of Hisun Pharmaceutical was the smell, or rather the lack of it. It was as if the sewage system had been scrubbed with ammonia, leaving only a sickly sweet aroma strong enough to overpower the stench of human waste.
In less than a minute, though, he realized that the company had exposed him to something far more noxious than feces. He had been sent, unwittingly, to release chemical runoff that Hisun had collected haphazardly beneath the factory, possibly to avoid paying fees to dispose of toxic waste.
PHOTO: NY TIMES
Shen's chest constricted. His breathing grew labored, his head faint. Then Feng Huaping, his brother-in-law and fellow migrant worker, who had climbed down first, gasped, "Grab my hand, get me out," before collapsing in a puddle of muck.
PHOTO: NY TIMES
Shen was the lucky one. He emerged with migraines and lung congestion, and doctors are still trying to diagnose the illness that is causing them. Feng died that night. A third migrant worker, Tang Dejun, also died in Hisun's fetid plumbing after he was sent down to finish the job the next day.
Hisun is one of China's leading exporters of pharmaceutical products, certified by the US Food and Drug Administration and the European drug commission to sell lifesaving anti-tumor and cardiovascular medications for prices Western manufacturers cannot match.
PHOTO: NY TIMES
But the company may pay more attention to fighting cancer in America than in protecting the health of its own workers and neighbors in Taizhou, a seaside industrial city where the air and water bear Hisun's inky signature.
Hisun declined to answer detailed written questions about the incident, as did the police in Taizhou. But a local government official confirmed the deaths, which occurred in August and said they were the subject of a continuing criminal investigation.
Hisun has sprouted quickly, growing from a tiny state-owned drug maker to a pharmaceutical and chemical conglomerate, with shares listed on the Shanghai Stock Exchange and some powerful foreign partners. But company employees and local residents say that it has never stopped dumping untreated chemical waste around Taizhou and that it has minimized or ignored the harmful effects of poisonous substances on its own workers.
"They were reckless to send us down there without protection," said Shen, now recuperating in a nearby hospital. "To send another guy down the next day is beyond belief. They have no regard for human life."
Such disregard appears all too common as China booms. The country's economy is growing faster than any other. But the air and water in many of its leading cities rank as the dirtiest in the world and the country as a whole has by far the world's highest number of workplace fatalities, reaching 11,500 through the first nine months of this year, up nearly 10 percent from the same period last year.
Much of China's economic boom has stemmed from foreign investment and international partnership. Hisun itself has become partners with the Drug Source Co, a distributor of generic drugs based in Westchester, Illinois.
The American company helped Hisun gain regulatory approval to make ingredients for a variety of drugs, including the top-selling anti-tumor medication doxorubicin, used to treat cancer patients. The drugs sold in the US are Hisun's most profitable product lines and are its fastest growing source of revenue, according to reports it has filed as a publicly listed company.
Drug Source did not answer phone and e-mail messages seeking comment about its relations with the company.
Hisun has undergone seven inspections by the FDA in recent years. They were intended to ensure that the company meets US standards for product safety. Hisun passed the inspections and it is now certified to sell ingredients for at least eight medicines to the US, all distributed by Drug Source.
Eli Lilly & Co has also joined with Hisun to produce Lilly's drug capreomycin, used to fight resistant strains of tuberculosis. Similar alliances have helped Hisun crack the European market for pravastatin sodium, which lowers cholesterol levels in heart patients.
A spokesman for Eli Lilly said the company had no knowledge of environmental or safety problems at Hisun. The FDA declined to answer questions about its inspections of Hisun or its certification process.
Hisun's case suggests that the enormous human and environmental toll of China's rapid development is not just an unintended side effect but also an explicit choice of business executives and officials who tolerate deaths and degradation as the inevitable price of progress.
Taizhou's main industrial area, Yantou, where the Jiaojiang River meets the East China Sea, was historically popular among fisherman, who used the river as a sheltered harbor.
In the mid-1980s, the local government renamed the area the Yantou Pharmaceutical Chemical Industry Zone, with state-owned Hisun as the anchor tenant. The authorities built concrete barricades along the beach to protect factories from the tides, rendering parts of the seashore inaccessible.
Hisun initially focused on the Chinese market and produced anti-parasite medicines used by veterinarians to treat farm animals.
But over the past several years, it has ventured into foreign markets with the help of its powerful North American allies.
Powered by exports, Hisun's sales are on track to hit US$150 million this year and its campus of white-and-blue tiled factories and offices has expanded to cover dozens of acres along the waterfront.
Yet one of Hisun's comparative advantages seems to be that it does not spend much money to treat toxic chemicals that are byproducts of producing these drugs.
Internal reports by local and national environmental investigators have found that each year, Hisun and other nearby companies release 3.6 million tonnes of water laden with organic and inorganic compounds that receive little or no processing.
Yantou's shoreline is edged with sludge. Inland, the air is sulfureous. Fishermen say river water and sea water causes their hands and legs to become ulcerated, in some extreme cases requiring amputation.
Some 1,700 villagers have left the area around Yantou in recent years, according to one national environmental report.
The effect on some of Hisun's own employees has also been severe.
Until recently, Cao Hongshai was a Hisun assembly line worker who made a deworming medicine that the FDA approved for sale in the US.
Cao said she used toluene, a toxic solvent, to produce the active ingredient in the drug. But she wore only a blue cotton uniform and worked in a room that had no special ventilation.
Cao says she has not suffered health problems except for irregular periods. But two years ago she gave birth to a girl who had stubs where eight of her fingers should have been.
Cao and her husband, Lin Jianyong, sued Hisun for damages. A report submitted to the court by the government-run Medical Information Institute in Zhejiang Province found a "clear correlation" between the child's defects and the chemicals used at Hisun. But local courts have consistently supported Hisun, and Lin and Cao have nearly exhausted the family's savings fighting the company.
Cao and Lin named their daughter after Hisun. Lin said they selected the name so that their daughter will always know that her deformity was the company's fault.
Local government officials have recently taken steps to clean up Yantou. Authorities opened a waste-water treatment facility just a short walk from Hisun's campus, and local companies are now required to channel their runoff there and pay for it to be processed.
Beijing has also expressed alarm. After two reporters for the New China News Agency wrote an unpublished internal report revealing Yantou's environment woes, Prime Minister Wen Jiabao (
But by the accounts of Hisun employees and some local officials, the company became adept at fending off such inquiries.
On Aug. 14, word spread at Hisun that a central government inspection team was to arrive from Beijing. Employees said their managers became unusually active in seeking to clean up the facility.
Shen, the migrant worker who handled construction jobs for Hisun, noticed people bustling about the factory that day. But it was not until night that he and Feng were recruited to help the company prepare for inspections.
A boss came looking for Feng at the temporary shacks where he and Shen lived, together with their wives and young children, all of them migrants from southwestern Sichuan Province. Hisun's plant is located nearby, across a foul-smelling canal that provides shipping passage to the sea.
The boss explained that Hisun had a problem that needed immediate attention. Feng, who led his own construction brigade, was told to pick a colleague and bring flashlights, a sledgehammer and a drill. Feng roused Shen, his brother-in-law.
Shen said the boss told them what to do. They were to knock down barricades that had been built inside Hisun's sewage system to redirect the flow of liquid waste. He did not explain why.
It seems quite likely, some other employees and local residents said, that the company had diverted waste water to avoid paying fees to have it processed, and that pending inspections prompted the company to restore the flow.
Feng stripped off his shirt and climbed down a manhole. Shen followed a few steps behind. He said he expected to smell human waste, but instead encountered the light chemical odor. He felt dizzy.
Feng had just begun working below when he cried out and reached for help. Shen grabbed his bare arm, wet and slippery, and pulled with all his strength. He tugged so hard that he bit off the tip of his tongue. The shot of pain in his mouth is his last memory that night.
When Shen regained consciousness two days later, blurry and disoriented in the hospital, he asked for Feng. He was told his brother-in-law was dead.
So was Tang, the other migrant construction worker who followed them into the drainage pipes the second night, and a security guard involved in a rescue attempt.
A local government official, Wang, who declined to provide his full name or have his title used, said a deputy general manager of Hisun and a lower-level official in charge of the drainage system were under investigation.
Hisun itself was fined the equivalent of US$5,400, this official said. Relatives of Feng said Hisun paid them US$20,500 compensation.
The local official said Bai Hua, Hisun's chief executive, was also assessed a personal fine. But neither Bai nor his company has said anything publicly about the case.
Bai this week headed his company's delegation to a major pharmaceutical convention in Frankfurt, where it promoted its line of drugs to fight heart disease, certified safe by the European Union.
In late October of 1873 the government of Japan decided against sending a military expedition to Korea to force that nation to open trade relations. Across the government supporters of the expedition resigned immediately. The spectacle of revolt by disaffected samurai began to loom over Japanese politics. In January of 1874 disaffected samurai attacked a senior minister in Tokyo. A month later, a group of pro-Korea expedition and anti-foreign elements from Saga prefecture in Kyushu revolted, driven in part by high food prices stemming from poor harvests. Their leader, according to Edward Drea’s classic Japan’s Imperial Army, was a samurai
The following three paragraphs are just some of what the local Chinese-language press is reporting on breathlessly and following every twist and turn with the eagerness of a soap opera fan. For many English-language readers, it probably comes across as incomprehensibly opaque, so bear with me briefly dear reader: To the surprise of many, former pop singer and Democratic Progressive Party (DPP) ex-lawmaker Yu Tien (余天) of the Taiwan Normal Country Promotion Association (TNCPA) at the last minute dropped out of the running for committee chair of the DPP’s New Taipei City chapter, paving the way for DPP legislator Su
It’s hard to know where to begin with Mark Tovell’s Taiwan: Roads Above the Clouds. Having published a travelogue myself, as well as having contributed to several guidebooks, at first glance Tovell’s book appears to inhabit a middle ground — the kind of hard-to-sell nowheresville publishers detest. Leaf through the pages and you’ll find them suffuse with the purple prose best associated with travel literature: “When the sun is low on a warm, clear morning, and with the heat already rising, we stand at the riverside bike path leading south from Sanxia’s old cobble streets.” Hardly the stuff of your
April 22 to April 28 The true identity of the mastermind behind the Demon Gang (魔鬼黨) was undoubtedly on the minds of countless schoolchildren in late 1958. In the days leading up to the big reveal, more than 10,000 guesses were sent to Ta Hwa Publishing Co (大華文化社) for a chance to win prizes. The smash success of the comic series Great Battle Against the Demon Gang (大戰魔鬼黨) came as a surprise to author Yeh Hung-chia (葉宏甲), who had long given up on his dream after being jailed for 10 months in 1947 over political cartoons. Protagonist